These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28711413)

  • 1. [Hypofractionated stereotactic radiotherapy for brain metastasis: Benefit of additional whole brain radiotherapy?].
    Royer P; Salleron J; Vogin G; Taillandier L; Clément-Duchêne C; Klein O; Faivre JC; Peiffert D; Bernier V
    Cancer Radiother; 2017 Dec; 21(8):731-740. PubMed ID: 28711413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofractionated stereotactic radiotherapy for challenging brain metastases using 36 Gy in six fractions.
    Dumont Lecomte D; Lequesne J; Geffrelot J; Lesueur P; Barraux V; Loiseau C; Lacroix J; Leconte A; Émery É; Thariat J; Stefan D
    Cancer Radiother; 2019 Dec; 23(8):860-866. PubMed ID: 31677901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk of radionecrosis after hypofractionated stereotactic radiotherapy targeting the postoperative resection cavity of brain metastases].
    Keller A; Doré M; Antoni D; Menoux I; Thillays F; Clavier JB; Delpon G; Jarnet D; Bourrier C; Lefebvre F; Chibbaro S; Darié I; Proust F; Noël G
    Cancer Radiother; 2017 Aug; 21(5):377-388. PubMed ID: 28551018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer.
    Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L; Zhang XM
    J Neurosurg; 2012 Dec; 117 Suppl():49-56. PubMed ID: 23205789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.
    Niibe Y; Nishimura T; Inoue T; Karasawa K; Shioyama Y; Jingu K; Shirato H
    BMC Cancer; 2016 Aug; 16(1):659. PubMed ID: 27542716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic radiotherapy following surgery for brain metastasis: Predictive factors for local control and radionecrosis.
    Doré M; Martin S; Delpon G; Clément K; Campion L; Thillays F
    Cancer Radiother; 2017 Feb; 21(1):4-9. PubMed ID: 27955888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionated stereotactic radiotherapy using intensity-modulated radiotherapy in patients with one or two brain metastases.
    Narayana A; Chang J; Yenice K; Chan K; Lymberis S; Brennan C; Gutin PH
    Stereotact Funct Neurosurg; 2007; 85(2-3):82-7. PubMed ID: 17167236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of brain oligometastases with hypofractionated stereotactic radiotherapy utilising volumetric modulated arc therapy.
    Croker J; Chua B; Bernard A; Allon M; Foote M
    Clin Exp Metastasis; 2016 Feb; 33(2):125-32. PubMed ID: 26482476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypofractionated stereotactic radiotherapy for brain metastases].
    Schlienger M; Nataf F; Huguet F; Pene F; Foulquier JN; Orthuon A; Roux FX; Touboul E
    Cancer Radiother; 2010 Apr; 14(2):119-27. PubMed ID: 20004125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionated stereotactic radiotherapy alone without whole-brain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull.
    Aoyama H; Shirato H; Onimaru R; Kagei K; Ikeda J; Ishii N; Sawamura Y; Miyasaka K
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):793-800. PubMed ID: 12788187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyberknife
    Telentschak S; Ruess D; Grau S; Goldbrunner R; von Spreckelsen N; Jablonska K; Treuer H; Kocher M; Ruge M
    J Cancer Res Clin Oncol; 2021 Sep; 147(9):2765-2773. PubMed ID: 33638006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypofractionated Stereotactic Radiosurgery and Radiotherapy to Large Resection Cavity of Metastatic Brain Tumors.
    Lima LC; Sharim J; Levin-Epstein R; Tenn S; Teles AR; Kaprealian T; Pouratian N
    World Neurosurg; 2017 Jan; 97():571-579. PubMed ID: 27777153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofractionated stereotactic radiotherapy for brain metastases from lung cancer : Evaluation of indications and predictors of local control.
    Ishihara T; Yamada K; Harada A; Isogai K; Tonosaki Y; Demizu Y; Miyawaki D; Yoshida K; Ejima Y; Sasaki R
    Strahlenther Onkol; 2016 Jun; 192(6):386-93. PubMed ID: 27169391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosurgery or Fractionated Stereotactic Radiotherapy plus Whole-brain Radioherapy in Brain Oligometastases: A Long-term Analysis.
    Balducci M; Autorino R; Chiesa S; Mattiucci G; Pompucci A; Azario L; D'Agostino GR; Ferro M; Fiorentino A; Fersino S; Mazzarella C; Colosimo C; Frascino V; Anile C; Valentini V
    Anticancer Res; 2015 May; 35(5):3055-9. PubMed ID: 25964595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors.
    Yamamoto M; Kawabe T; Sato Y; Higuchi Y; Nariai T; Watanabe S; Kasuya H
    J Neurosurg; 2014 Dec; 121 Suppl():16-25. PubMed ID: 25434933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypofractionated conformal stereotactic radiotherapy alone or in combination with whole-brain radiotherapy in patients with cerebral metastases.
    Lindvall P; Bergström P; Löfroth PO; Henriksson R; Bergenheim AT
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1460-6. PubMed ID: 15817351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes Following Hypofractionated Stereotactic Radiotherapy in the Management of Brain Metastases.
    Ahmed KA; Sarangkasiri S; Chinnaiyan P; Sahebjam S; Yu HH; Etame AB; Rao NG
    Am J Clin Oncol; 2016 Aug; 39(4):379-83. PubMed ID: 24755663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
    Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
    J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HFSRT of the resection cavity in patients with brain metastases.
    Specht HM; Kessel KA; Oechsner M; Meyer B; Zimmer C; Combs SE
    Strahlenther Onkol; 2016 Jun; 192(6):368-76. PubMed ID: 26964777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.